期刊文献+

人类新基因CTRP4的原核表达及多克隆抗体的制备 被引量:6

Prokaryotic expression and polyclonal antibody preparation of human novel gene CTRP4
下载PDF
导出
摘要 目的:构建新基因CTRP4的原核表达载体,在大肠杆菌中表达并纯化rhCTRP4-his蛋白,制备和鉴定小鼠抗人CTRP4多克隆抗体,为进一步研究人类新基因CTRP4的生物学功能奠定基础。方法:从pcDNA3.1-myc/his(-)B-hCTRP4重组载体中通过PCR的方法扩增CTRP4基因ORF中不含信号肽的目的基因片段,将得到的片段双酶切定向插入pET-32a中,构建原核表达载体pET-32a-hCTRP4。构建好的质粒在E.coli BL21(DE3)中进行诱导、表达,通过镍亲和层析柱纯化融合蛋白,SDS-PAGE电泳分析蛋白纯度。将pcDNA3.1-myc/his(-)B-hCTRP4重组质粒和纯化好的融合蛋白依次免疫BALB/c小鼠,制备多克隆抗体。并对抗体进行纯化、效价测定以及特异性鉴定。结果:DNA测序证实构建的pET-32a-hCTRP4重组表达载体含有hCTRP4编码序列,其序列比对分析与GenBank中公布序列一致,质粒在E.coli中表达相对分子质量(Mr)为35 000的目的蛋白,SDS-PAGE电泳分析纯度为95%以上。ELISA法检测抗体效价为1∶20 000,Westernblot、免疫荧光细胞化学和免疫组化分析显示抗体能特异性识别重组hCTRP4以及天然状态hCTRP4蛋白。结论:成功构建了hCTRP4蛋白的原核表达载体,并获得较高纯度的融合蛋白,制备了高效价、高特异性的多克隆抗体。 AIM: To further investigate the biological function of human novel gene CTRP4 by constructing the prokaryotic expression vector of human CTRP4, inducing the expression of and purifying hCTRP4-his protein in E. coli, and preparing polyclonal antibody against human CTRP4. METHODS: Human CTRP4 gene was amplified by PCR, digested with enzymes, and subcloned into a his-tagged prokaryotic expression vector to generate a recombinant plasmid named pET-32a-hCTRP4. The pET-32a-hCTRP4 was transformed into E. coli BL21 (DE3). The hCTRP4-his fusion protein was induced by IPTG, purified by Ni-NTA purification system, and analyzed by SDS-PAGE. The recombinant vector pcDNA3.1-myc/his(-) B-hCTRP4 expressing full-length human CTRP4 and purified prokaryotic protein hCTRP4 were used to immunize BALB/c mice to produce polyclonal antibody. The anti-serum was purified and the characteristics of the antibody were identified by ELISA, Western blotting, immunofluorescence cytochemistry and immunohistochemistry. RESULTS: The prokaryotic expres- sion vector of pET-32a-hCTRP4 was constructed successful- ly. hCTRP4-his fusion protein was expressed in E. coli BL21 (DE3) after IPTG induction. The titer of the anti-serum reached 1:20 000, and its specificity was proved by Western blotting. The results of immunofluorescence cytochemistry and immunohistochemistry indicated that CTRP4 was mainly localized in the cytoplasm of hepatic cells. CONCLUSION: hCTRP4-his fusion protein can be successfully expressed in E. coil A specific polyclonal antibody against human CTRP4 has been successfully prepared.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第6期614-617,622,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(91129707 30971483)
关键词 CTRP4 原核表达 基因免疫 多克隆抗体 CTRP4 prokaryotic expression genetic immunization polyclonal antibody
  • 相关文献

参考文献7

  • 1Kishore U, Gaboriaud C, Waters P, et al. Clq and tumor necrosis factur superfamily : modularity and versatility [ J ]. Trends Immunol, 2(104, 25(10) : 551 -561.
  • 2SchMfler A, Buechler C. CTRP family: linking immunity to metabo- lism[ J]. Trends Endocrinol Metab, 2012.
  • 3I Schaffler A, Schohnerich J, Salzberger B. Adipose tissue as an immu- nological organ: Toll-like receptors, Clq/TNFs and CTRPs [ J]. Trends hnmunol, 2007, 28 (9) : 393 - 399.
  • 4栾好飞,高新,卞丽红,付洁,邱伟成,董立厚,范礼斌,宋海峰.活体电穿孔法辅助HE4基因免疫小鼠制备单克隆抗体[J].细胞与分子免疫学杂志,2010,26(7):660-662. 被引量:2
  • 5李玲玲,江冠民,张革,王昊,方瑞,杜军.人源Nodal成熟肽的原核表达及多克隆抗体的制备[J].细胞与分子免疫学杂志,2011,27(8):880-882. 被引量:4
  • 6Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, et al. Molecular, biochemical and functional characterizations of C1 q/TNF family mem-bers : adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinato- rial associations and metabolic functions [ J]. Biochem J, 2008, 416 (2) : 161 - 177.
  • 7Li Q, Wang L, Tan W, et al. Identification of ClqTNF-related pro- tein 4 as a potential cytokine that stimulates the STAT3 and NF-kap- paB pathways and promotes cell survival in human cancer cells [ J ]. Cancer Lett, 2011, 308(2) : 203 -214.

二级参考文献18

  • 1孙智慧,孟安明.斑马鱼胚胎中受Nodal信号调控基因的鉴定[J].生物化学与生物物理进展,2007,34(6):595-603. 被引量:7
  • 2Schummer M, Ng WV, Bumgarner RE, et al. Comparative hybridization of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas[J]. Gene, 1999, 238(2) : 375 -385.
  • 3Drapkin R, yon Horsten HH, Lin Y, et al. Human epididymis protein 4 (HFA) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas [ J ]. Cancer Res, 2005, 65 ( 6 ) : 2162 - 2169.
  • 4Hellstrom I, Raycraft J, Hayden-kedbetter M, etal. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma[J]. Cancer Res, 2003, 63(13) : 3695 -3700.
  • 5Moore RG, Brown Ak, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass[ J]. Gynecol Oncol, 2008, 108(2) : 402 -408.
  • 6Havrilesky LJ, Whitehead CM, Rubatt JM, et al. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence [ J ]. Gynecol Oncol, 2008, 110 ( 3 ) : 374 - 382.
  • 7Ulmer JB, Wahren B, Liu MA. Gene-based vaccines: recent technical and clinical advances[ J]. Trends Mol Med, 2006, 12 (5) : 216 - 222.
  • 8Otten G, Schaefer M, Doe B, et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation [ J ]. Vaccine, 2004, 22 (19) : 2489 -2493.
  • 9Shen MM. Nodal signaling: developmental roles and regulation [ J]. Development, 2007, 134(6): 1023- 1034.
  • 10Topczewska JM, Postovit LM, Margaryan NV, et al. Embryonic and tumorigenic pathways converge via Nodal signMing: Role in melanoma aggressiveness [ J]. Nat Med, 2006, 12 ( 8 ) : 925 - 932.

共引文献4

同被引文献61

  • 1张辰艳,黄原.线粒体DNA基因表达的转录及其调控[J].生命的化学,2006,26(2):113-116. 被引量:4
  • 2郭雪艳,时永全,翟惠虹,孙力,刘理礼,韩霜,雷婷,樊代明.人核糖体蛋白S13的原核表达、纯化及多克隆抗体的制备[J].细胞与分子免疫学杂志,2007,23(4):363-366. 被引量:4
  • 3Bast RC. Jr, Feeney M, Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma[ J]. J Clin Invest, 1981, 68 (5) : 1331 -1337.
  • 4Yin BW, Dnistrian A, Lloyd KO. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene[ J]. Int J Cancer, 2002, 98 (5) : 737 - 740.
  • 5Scholler N, Urban N. CA125 in ovarian cancer[J]. Biomark Med, 2007, 1(4) : 513 -523.
  • 6O'Brien TJ, Beard JB, Underwood LJ, et al. The CA125 gene: an exla'aceUular superstructure dominated by repeat sequences[J]. Tumor Biol, 2001, 22(6) : 348 -366.
  • 7Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16 [J]. J Biol Chem, 2001, 276 (29) : 27371 -27375.
  • 8Randall LM, Sill MW, Burger RA, et al. Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a gynecologic oncology group phase II trial[J]. Gynecol Oncol, 2012, 124(3) : 563 - 568.
  • 9] Patankar MS, Jing Y, Morrison JC, et al. Potent suppression of natu- ral killer cell response mediated by the ovarian tumor marker CA125 [J], Gynecol Oncol, 2005, 99(3) : 704 -713.
  • 10Belisle JA, Gubbels JA, Raphael CA, et al. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125) [J]. Immunology, 2007, 122(3) : 418 -429.

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部